The Valley Desk

ArticleCurrent medical research and opinionPublished

Cost comparison between apixaban and low molecular weight heparin (LMWH) among venous thromboembolism (VTE) patients with cancer

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Bristol Myers Squibb. Affiliation source

Publication record

Type
Article
Venue
Current medical research and opinion
Published
Subject terms
Humans; Neoplasms; Hemorrhage; Pyrazoles; Pyridones; Heparin, Low-Molecular-Weight; Retrospective Studies; Adult; Aged; Middle Aged; Health Care Costs; Female
PubMed ID
42696476
Added to directory
Source checked

Report a correction or request removal